Preemptive use of etoricoxib 90 mg, ibuprofen 600 mg and nimesulide 100 mg shows favorable pain-control outcomes in single-implant procedures, while meloxicam 15 mg and tenoxicam 20 mg show efficacy in more invasive, multiple-implant surgeries.
Postoperative pain, swelling, and restricted mouth opening can impact recovery after dental implant placement. Could administering anti-inflammatory medication prior to surgery help diminish these complications? A systematic review, led by Eduardo Gomes da Frota et al., explored the efficacy and safety of preemptive oral corticosteroids and nonsteroidal anti-inflammatory drugs (NSAIDs) in adults undergoing dental implant surgery.
A comprehensive literature search was executed across the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (via PubMed), Excerpta Medica Database (EMBASE), Virtual Health Library (VHL), Web of Science and other databases, without restrictions on language or publication date.
The review included 7 randomized clinical trials (RCTs) involving 589 patients. Studies comparing oral corticosteroids or nonsteroidal anti-inflammatory drugs (NSAIDs) with placebo or other anti-inflammatory agents were considered. The key outcomes were postoperative pain, facial edema, trismus, postoperative discomfort, and requirement for rescue medication.
Key insights from the synthesis include:
Although preemptive anti-inflammatory therapy portrays potential for alleviating postoperative pain in implant dentistry, differences in drug regimens, surgical protocols and outcome assessments prevent the identification of a universally preferred agent. The authors highlight the need for larger and methodologically standardized trials to strengthen evidence-based analgesic strategies.
The Journal of Oral Implantology
Preemptive Analgesia With Steroidal and Nonsteroidal Anti-Inflammatory Drugs in Dental Implant Surgeries: A Systematic Review
Eduardo Gomes da Frota et al.
Comments (0)